Caprock Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,988
| Closed | -$365K | – | 579 |
|
2021
Q2 | $365K | Sell |
1,988
-85
| -4% | -$15.6K | 0.03% | 312 |
|
2021
Q1 | $317K | Buy |
2,073
+50
| +2% | +$7.65K | 0.03% | 321 |
|
2020
Q4 | $316K | Buy |
+2,023
| New | +$316K | 0.04% | 312 |
|
2019
Q1 | – | Sell |
-2,463
| Closed | -$240K | – | 409 |
|
2018
Q4 | $240K | Buy |
+2,463
| New | +$240K | 0.06% | 280 |
|